Resources

Featured

Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts
July 2018

Fuelled by political will, resources for cost-effective, evidence-based prevention programmes and revolutionary advances in hepatitis C virus (HCV) treatment, momentum is building towards halting a deadly global epidemic. Worldwide, an estimated 71 million people are living with hepatitis C, a blood- borne virus that infects liver cells.

Read more